Revenio Group (REG1V) investor relations material

Executive summary

• Q1 net sales reached EUR 27.3 million, up 4.8% year-over-year (8.4% currency-adjusted), with strong growth in the US and Europe, while APAC lagged due to tough comparables and currency headwinds.

• Operating profit dropped 63.8% to EUR 2.4 million, impacted by EUR 3.1 million in one-off costs related to the Visionix acquisition and organizational changes.

• Adjusted operating profit was EUR 5.8 million, down 12.2% year-over-year; adjusted operating profit margin was 21.3% of sales.

• Cash flow from operations was negative at EUR -3.4 million, mainly due to increased accounts receivable and higher tax payments.

• Visionix acquisition expands the addressable market from $1 billion to $2.5 billion, broadens the product portfolio, and is expected to accelerate growth and value creation.

Financial highlights

• Gross margin decreased to 68.4% from 72.6% year-over-year, impacted by tariffs, FX headwinds, and product mix.

• EBITDA declined 54.9% to EUR 3.5 million.

• EPS dropped to EUR 0.092 from EUR 0.157 in Q1 2025.

• Equity ratio remained high at 79.1%.

• Net cash flow from operations at EUR -3.4 million.

Outlook and guidance

• Previous financial guidance withdrawn due to the Visionix transaction; updated guidance to be provided post-completion.

• Long-term targets include annual growth at 3x market rate and EBITDA margin of 25% for 2028–2029, approaching 30% beyond 2030.

• EUR 20 million EBITDA uplift targeted by 2029, with 70% expected by 2027.

• No dividend proposed for the financial year 2025.